Oxford Gene Technology Ltd. Invites You to Catapult Santa to Win an Amazon Kindle 3G

Oxford, UK – 13 December 2011. Help Santa save Christmas with Oxford Gene Technology’s (OGT’s) Santa catapult game. Challenge your friends and colleagues today to see if you can make Santa travel the furthest distance, with the best score winning an Amazon Kindle 3G! As in previous years, OGT has decided to send an electronic Christmas card this year, and will be making a donation to a number of charities in lieu of sending paper cards. For further information about the charities supported by OGT, including how to make a donation, please visit the corporate social responsibility page on the company’s brand new website. The new content-rich site utilises a totally new webpage design that maximises usability and provides authoritative insight into the latest developments, tools and issues in genomics research. Visit the new site now to play the game or to find out more about OGT’s clinical genetics, genomic services and diagnostic biomarker solutions.

For further information, please contact:

Oxford Gene Technology, Begbroke Science Park, Sandy Lane, Yarnton, Oxford OX5 1PF

T: +44 (0) 1865 856826 ; F: +44 (0) 1865 848684 ; E: products@ogt.co.uk

W: www.ogt.co.uk

About Oxford Gene Technology

Founded by Professor Ed Southern, Oxford Gene Technology (OGT) provides innovative clinical genetics and diagnostic solutions to advance molecular medicine. www.ogt.co.uk.

Clinical & Genomic Solutions: OGT’s Genefficiency™ is a unique combination of world-leading platforms, people, processing power and performance synchronised to deliver rapid, high-quality genomic data to customers worldwide. OGT’s CytoSure™ cytogenetics array, labelling and interpretation software products and services provide a complete solution for the detection of chromosomal abnormalities. Together, Genefficiency and CytoSure offer a unique, standardised and integrated solution for cytogenetics research.

Biomarker Discovery: OGT delivers tailored biomarker discovery solutions that optimise drug and diagnostic development programmes. With expertise in genomic and proteomic diagnostic biomarkers, OGT provides highly specific customised biomarker panels for cancer and other diseases, both for direct sale and also for collaboration with partner companies.